These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 34794)

  • 1. "Clonal selection and after," and after.
    Gershon RK
    N Engl J Med; 1979 May; 300(19):1105-7. PubMed ID: 34794
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft-versus-leukaemia after bone marrow transplantation.
    Barret AJ
    Pediatr Med Chir; 1991; 13(1):9-13. PubMed ID: 2052462
    [No Abstract]   [Full Text] [Related]  

  • 3. The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD?
    Slavin S; Ackerstein A; Naparstek E; Or R; Weiss L
    Bone Marrow Transplant; 1990 Sep; 6(3):155-61. PubMed ID: 2252954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunology of bone marrow grafts].
    Dreyfus F
    Ann Med Interne (Paris); 1986; 137(8):617-20. PubMed ID: 3551717
    [No Abstract]   [Full Text] [Related]  

  • 5. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 6. The transplantation of bone marrow.
    Jacobs P
    Cent Afr J Med; 1978 Sep; 24(9 Suppl):33-42. PubMed ID: 31240
    [No Abstract]   [Full Text] [Related]  

  • 7. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host.
    Hummel S; Wilms D; Vitacolonna M; Zöller M
    J Leukoc Biol; 2002 Nov; 72(5):898-912. PubMed ID: 12429711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
    Zeis M; Uharek L; Glass B; Gaska T; Gassmann W; Mueller-Ruchholtz W
    Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Leu-7-positive T lymphocytes during cytomegalovirus infection following allogeneic bone marrow transplantation for hematologic malignancies.
    Forman SJ; Zaia JA; Wright C; Gallagher MT; Blume KG
    Transplantation; 1986 Feb; 41(2):268-71. PubMed ID: 3003978
    [No Abstract]   [Full Text] [Related]  

  • 11. [Donor leukocyte transfusion in a patient with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation: analysis of natural killer cell activity and T-cell receptor repertoire in bone marrow T cells that exhibited graft-versus-leukemia activity].
    Suehiro Y; Muta K; Umemura T; Motomura S; Nishimura J; Nawata H; Kimura N
    Rinsho Ketsueki; 1999 Jan; 40(1):40-5. PubMed ID: 10067095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Of mice and men in bone marrow transplantation.
    Mathé G; Schwarzenberg L; Halle-Pannenko O; Abuaf N; Pouillart P
    Transplant Proc; 1977 Mar; 9(1):155-68. PubMed ID: 17189
    [No Abstract]   [Full Text] [Related]  

  • 13. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Emergency problems of the graft vs host reaction (literature survey)].
    Shevelev AS
    Probl Gematol Pereliv Krovi; 1976 Apr; 21(4):35-41. PubMed ID: 16257
    [No Abstract]   [Full Text] [Related]  

  • 16. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone marrow transplantation].
    Rozman C
    Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(3):125-40. PubMed ID: 3912945
    [No Abstract]   [Full Text] [Related]  

  • 18. Aberrations of suppressor T cells in human graft-versus-host disease.
    Reinherz EL; Parkman R; Rappeport J; Rosen FS; Schlossman SF
    N Engl J Med; 1979 May; 300(19):1061-8. PubMed ID: 34791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel cell surface antigen (T305) found in increased frequency on acute leukemia cells and in autoimmune disease states.
    Fox RI; Hueniken M; Fong S; Behar S; Royston I; Singhal SK; Thompson L
    J Immunol; 1983 Aug; 131(2):762-7. PubMed ID: 6602845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.